Todd Harris, Chief Executive Officer at Tyra Biosciences, Inc. (TYRA), sold 4,327 shares at $16.05 ($70K) on 2023-03-31, disclosed to the SEC on 2023-03-31.
Scheduled sale ($70k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.18 | 1,420 | $23K | 33.0% |
| 2 | $16.02 | 2,407 | $39K | 55.4% |
| 3 | $16.05 | 500 | $8K | 11.5% |
| Total | $16.08 avg | 4,327 | $70K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |